BETHESDA, Md., Sept. 10, 2013 /PRNewswire-USNewswire/ – What Drives Continuous Quality Improvements? That is the question that pharmaceutical industry experts and regulators will address at the 2013 PDA Pharmaceutical Quality Metrics Conference.
The program deals with the issues faced in identifying and defining meaningful, measurable and manageable quality metrics that drive continuous improvement in the global drug supply. The FDA is also evaluating using quality metrics as an input into its inspectional risk model to better focus resources.
Representatives from branded and generic manufacturers, contract manufacturing organizations and regulators will be on hand leading discussions, breakout groups and plenary sessions. This two-day conference is designed for professionals working in supply chain, clinical supply materials preparation, and quality, regulatory or executive management. The meeting will be led by FDA and industry executives who are heads of quality.
TOP REASONS TO ATTEND:
- Better understand FDA's vision for using Quality Metrics as a input into their inspectional risk model.
- Learn "best practices" for Quality Metrics that promote continuous improvement.
- Hear about case studies on Product Quality Metrics, Site and Quality Systems Metrics, and Cultural and Company Metrics.
This two-day conference will be held at the Bethesda North Marriott Hotel and Conference Center on Dec. 9-10, 2013. Members of the media are invited to attend.
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide. PDA's Annual Meeting will be held April 7-9, 2014 in San Antonio, Texas. For information, visit www.pda.org and follow PDA on LinkedIn.
Director of Marketing Services, Parenteral Drug Association® (PDA)
T: 301-656-5900, ext. 153